We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Pathway Found to Nerve Regeneration

By Biotechdaily staff writers
Posted on 14 Jul 2004
Researchers have discovered crucial processes involved in the regulation of nerve regeneration and growth that may fast-forward study in spinal cord research.

The report, published in the June 24, 2004 issue of the journal Neuron, for the first time describes how nerve growth factor (NGF) triggers a sequence of proteins--a molecular pathway--which in turn stimulates nerve growth. More...
"It is the first study to show the link between NGF and the building blocks that form the axon,” remarked Dr. William Snider, professor of neurology and cell and molecular physiology at the University of North Carolina (UNC, Chapel Hill, NC, USA) School of Medicine and director of the UNC Neuroscience Center.

Damage to the peripheral nervous system usually results in spontaneous regeneration and repair. However, this does not occur with the spinal cord, where disruption of connections from injury leads to paralysis. "The results of this study allow us to know more about how to promote axon growth and regeneration in the spinal cord,” said Dr. Fengquan Zhou, a coworker in Snider's lab and lead author of the study. Dr. Zhou took a unique approach in the study to locating missing pieces in the molecular pathway when he realized that NGF stimulation occurred in the growth cone of the axon. This simplified a complicated obstacle that had previously evaded others who did not focus on the growth cone.

Essentially, in the pathways Dr. Zhou identified, NGF signals the proteins P113K and GSK-3beta, and P13K, that then regulate another protein, APC, to assemble the axon from its building blocks, called microtubules. "This work helps us understand how an axon is put together and gives us a new idea about how we might make it happen after a spinal cord injury,” explained Dr. Zhou.





Related Links:
University of North Carolina

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.